B Mohanraj1, G R Meloni2, R L Mauck3, G R Dodge4. 1. McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: mbhavana@mail.med.upenn.edu. 2. McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: gmeloni@mail.med.upenn.edu. 3. McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA 19104, USA; Collaborative Research Partner Acute Cartilage Injury Program of AO Foundation, Davos, Switzerland; Translational Musculoskeletal Research Center, Philadelphia Veterans Administration Medical Center, Philadelphia, PA 19104, USA. Electronic address: lemauck@mail.med.upenn.edu. 4. McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Collaborative Research Partner Acute Cartilage Injury Program of AO Foundation, Davos, Switzerland; Translational Musculoskeletal Research Center, Philadelphia Veterans Administration Medical Center, Philadelphia, PA 19104, USA. Electronic address: gdodge@mail.med.upenn.edu.
Abstract
OBJECTIVE: A number of in vitro models of post-traumatic osteoarthritis (PTOA) have been developed to study the effect of mechanical overload on the processes that regulate cartilage degeneration. While such frameworks are critical for the identification therapeutic targets, existing technologies are limited in their throughput capacity. Here, we validate a test platform for high-throughput mechanical injury incorporating engineered cartilage. METHOD: We utilized a high-throughput mechanical testing platform to apply injurious compression to engineered cartilage and determined their strain and strain rate dependent responses to injury. Next, we validated this response by applying the same injury conditions to cartilage explants. Finally, we conducted a pilot screen of putative PTOA therapeutic compounds. RESULTS: Engineered cartilage response to injury was strain dependent, with a 2-fold increase in glycosaminoglycan (GAG) loss at 75% compared to 50% strain. Extensive cell death was observed adjacent to fissures, with membrane rupture corroborated by marked increases in lactate dehydrogenase (LDH) release. Testing of established PTOA therapeutics showed that pan-caspase inhibitor [Z-VAD-FMK (ZVF)] was effective at reducing cell death, while the amphiphilic polymer [Poloxamer 188 (P188)] and the free-radical scavenger [N-Acetyl-L-cysteine (NAC)] reduced GAG loss as compared to injury alone. CONCLUSIONS: The injury response in this engineered cartilage model replicated key features of the response of cartilage explants, validating this system for application of physiologically relevant injurious compression. This study establishes a novel tool for the discovery of mechanisms governing cartilage injury, as well as a screening platform for the identification of new molecules for the treatment of PTOA.
OBJECTIVE: A number of in vitro models of post-traumatic osteoarthritis (PTOA) have been developed to study the effect of mechanical overload on the processes that regulate cartilage degeneration. While such frameworks are critical for the identification therapeutic targets, existing technologies are limited in their throughput capacity. Here, we validate a test platform for high-throughput mechanical injury incorporating engineered cartilage. METHOD: We utilized a high-throughput mechanical testing platform to apply injurious compression to engineered cartilage and determined their strain and strain rate dependent responses to injury. Next, we validated this response by applying the same injury conditions to cartilage explants. Finally, we conducted a pilot screen of putative PTOA therapeutic compounds. RESULTS:Engineered cartilage response to injury was strain dependent, with a 2-fold increase in glycosaminoglycan (GAG) loss at 75% compared to 50% strain. Extensive cell death was observed adjacent to fissures, with membrane rupture corroborated by marked increases in lactate dehydrogenase (LDH) release. Testing of established PTOA therapeutics showed that pan-caspase inhibitor [Z-VAD-FMK (ZVF)] was effective at reducing cell death, while the amphiphilic polymer [Poloxamer 188 (P188)] and the free-radical scavenger [N-Acetyl-L-cysteine (NAC)] reduced GAG loss as compared to injury alone. CONCLUSIONS: The injury response in this engineered cartilage model replicated key features of the response of cartilage explants, validating this system for application of physiologically relevant injurious compression. This study establishes a novel tool for the discovery of mechanisms governing cartilage injury, as well as a screening platform for the identification of new molecules for the treatment of PTOA.
Authors: Soichiro Yasuda; DeWayne Townsend; Daniel E Michele; Elizabeth G Favre; Sharlene M Day; Joseph M Metzger Journal: Nature Date: 2005-07-17 Impact factor: 49.962
Authors: Michael A DiMicco; Parth Patwari; Patrick N Siparsky; Sanjay Kumar; Michael A Pratta; Michael W Lark; Young-Jo Kim; Alan J Grodzinsky Journal: Arthritis Rheum Date: 2004-03
Authors: Mihee Kim; Karen J Haman; Evelyne M Houang; Wenjia Zhang; Demetris Yannopoulos; Joseph M Metzger; Frank S Bates; Benjamin J Hackel Journal: Biomacromolecules Date: 2017-06-14 Impact factor: 6.988
Authors: Barbora Vesela; Martina Zapletalova; Eva Svandova; Alice Ramesova; Jaroslav Doubek; Hervé Lesot; Eva Matalova Journal: Cartilage Date: 2021-09-08 Impact factor: 3.117
Authors: Sebastian Knorz; Felix Kluge; Kolja Gelse; Stefan Schulz-Drost; Thilo Hotfiel; Matthias Lochmann; Björn Eskofier; Sebastian Krinner Journal: Orthop J Sports Med Date: 2017-07-24
Authors: Leonardo Punzi; Paola Galozzi; Roberto Luisetto; Marta Favero; Roberta Ramonda; Francesca Oliviero; Anna Scanu Journal: RMD Open Date: 2016-09-06
Authors: Amber T Collins; Micaela L Kulvaranon; Hattie C Cutcliffe; Gangadhar M Utturkar; Wyatt A R Smith; Charles E Spritzer; Farshid Guilak; Louis E DeFrate Journal: Arthritis Res Ther Date: 2018-10-17 Impact factor: 5.156